FeesSafety
Pluang+

Ethereum price drops over 2% amid $21M ETF outflows and bearish technical signals

Market News
29 Oct 2026, 13:13 WIB
Crypto news
View Source
Bearish
Ethereum price drops over 2% amid $21M ETF outflows and bearish technical signals

Ethereum's price fell 2.12% to around $2,318 on October 29, driven by $21.41 million in net outflows from U.S. spot Ethereum ETFs, particularly BlackRock's ETHA fund. The cryptocurrency faces technical weakness with bearish indicators and immediate support at $2,290-$2,300, while analysts warn of further downside if it breaks below this range. Large holders have sold about 160,000 ETH recently, increasing exchange balances and adding selling pressure. Despite this, some analysts see potential recovery if Ethereum can reclaim levels above $2,350-$2,400, though market conditions remain challenging and the upcoming Glamsterdam upgrade faces delays.

Ethereum price movement on October 29, 2026, is presented here with Pluang's market data as of Oct 29, 2026 16:31 WIB: Among 50 major cryptocurrencies priced on Pluang, 8 rose and 41 fell. Notable movers include VET (VeChain) at Rp111 with a 1-day change of -4.73%, GRT (The Graph) at Rp394 with -4.55%, and KSM (Kusama) at Rp66,556 with -4.48%.

More News

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...

Market News
Bullish
15 minutes ago
Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...

Company Fundamentals
Bullish
15 minutes ago
Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC have extended their partnership to include youth coach training, an annual Sports for All Summit, and sensory inclusion programs aimed at supporting neurodivergent children, especially those with ADHD, in...

Others
Bullish
1 hour ago
Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks announced that its CEO Adi Sfadia and CFO Gil Benyamini will attend the Deutsche Bank Global Space and Defense Tech Summit on November 18, 2026, in New York City. The event will feature one-on-one and group meetings, providin...

Market News
Neutral
1 hour ago
Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex Inc. has acquired Wind2, a UK-based renewable energy developer with about 350 MW of advanced wind projects across Scotland, England, and Wales. This acquisition strengthens Boralex's presence and capabilities in the UK, aligning with its stra...

Company Fundamentals
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App